Korean J Hematol.
2000 Feb;35(1):72-80.
Allogeneic Peripheral Blood Stem Cell Transplantation with Stepwise Donor Lymphocyte Infusions in Mantle Cell Lymphoma Relapsed after Autologous PBSCT
- Affiliations
-
- 1Department of Internal Medicine, Kyungpook National University, School of Medicine, Taegu, Korea.
- 2Department of Clinical Pathology, Kyungpook National University, School of Medicine, Taegu, Korea.
- 3Department of Internal Medicine, College of Medicine, Sung Kyun Kwan University, Seoul, Korea.
- 4Department of Internal Medicine, Yeungnam University, School of Medicine, Taegu, Korea.
Abstract
- Mantle cell lymphoma (MCL) is a distinctive clinicopathologic entity and represents 5~10% of all non-Hodgkin's Lymphoma (NHL). The median survival of patients with MCL is only 3 years, and none of the available conventional chemotherapy regimens appear curative. Encouraging results have been reported with high dose chemotherapy with stem cell transplantation for its treatment. Particularly, alloSCT appears to induce durable remission via graft-versus-lymphoma (GVL) effect. Donor lymphocyte infusions (DLIs), by virtue of graft-versus-tumor effect, have been shown to induce remissions in leukemia that recurs after alloSCT. But GVL effect of DLI has not been clearly established in NHL. We describe a patient with relapsed MCL shortly after high dose chemotherapy with autoSCT who was successfully treated with alloPBSCT. The patient presented with diffuse GI and spleeninvolvement at the time of alloPBSCT. The patient received Bu/Cy/VP-16 as preparative regimen followed by alloPBSCT. The patient received cyclosporin and methotrexate as GVHD prophylaxis. Prednisone was added after grade II GVHD. The patient had partial response by D+64. To enhance GVL effect, the patient received G-CSF primed DLI serially at D+64 and D+92. Grade IV GVHD developed 19 days after 2nd DLI and was partially controlled with a combination of cyclosporin, prednisone and mycophenolate mofetil. Clinical complete remission was observed at D+112, and maintained till last follow-up day (D+515). Our findings suggest that alloSCT and stepwise DLIs may offer a curative approach to MCL.
Keyword
MeSH Terms
-
Cyclosporine
Drug Therapy
Follow-Up Studies
Granulocyte Colony-Stimulating Factor
Humans
Leukemia
Lymphocytes*
Lymphoma, Mantle-Cell*
Lymphoma, Non-Hodgkin
Methotrexate
Peripheral Blood Stem Cell Transplantation*
Prednisone
Stem Cell Transplantation
Tissue Donors*
Virtues
Cyclosporine
Granulocyte Colony-Stimulating Factor
Methotrexate
Prednisone
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Scleroderma following Autologous Peripheral Stem Cell Transplantation
- A Case of Mantle Cell Lymphoma Treated with Autologous Stem Cell Transplantation and Rituximab
- Palliative effect of (131)I-MIBG in relapsed neuroblastoma after autologous peripheral blood stem cell transplantation
- Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
- Thrombotic Thrombocytopenic Purpura after Autologous Peripheral Blood Stem Cell Transplantation
